Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Aug 06, 2019	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001532176-19-000026.pdf 0001532176-19-000026.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jun 19, 2019	8-K	Report of unscheduled material events or corporate event	View HTML 0000930413-19-001896.pdf 0000930413-19-001896.xls
May 29, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-19-000016.pdf 0001237899-19-000016.xls
May 15, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-19-000012.pdf 0001237899-19-000012.xls
May 15, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-19-000013.pdf 0001237899-19-000013.xls
May 14, 2019	CT ORDER	CT ORDER	View HTML 9999999997-19-004343.pdf
May 09, 2019	CT ORDER	CT ORDER	View HTML 9999999997-19-004163.pdf
May 07, 2019	8-K/A	Amendment to a previously filed 8-K	View HTML 0000930413-19-001590.pdf 0000930413-19-001590.xls
May 07, 2019	8-K	Report of unscheduled material events or corporate event	View HTML 0001532176-19-000015.pdf 0001532176-19-000015.xls
May 07, 2019	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001532176-19-000017.pdf 0001532176-19-000017.xls EX-101.INS - XBRL INSTANCE DOCUMENT

Data provided by Kaleidoscope.

Investors & Media